The present invention relates generally to semiconductor device processing and, more particularly, to a method for forming non-amorphous, ultra-thin semiconductor devices using a sacrificial implantation layer.
The formation of ultra-shallow p+ and n+ doped regions within a silicon substrate is a crucial step in the fabrication of metal-oxide semiconductor (MOS) transistors and other semiconductor devices used within integrated circuits. The ever-decreasing size of MOS transistors requires a down scaling of all lateral and vertical dimensions of the transistor. In conventional scaling scenarios, the depth of the junctions, which form the source and drain regions of MOS transistors, scales linearly with gate length. Therefore, shallower junctions of p+ and n+ regions which have suitably low sheet resistance are required in the present semiconductor manufacturing industry.
In conventional semiconductor manufacturing processes, shallow junctions may be formed by ion implantation followed by an anneal such as a rapid thermal anneal (RTA). The reliability of this technique is known in the art down to a junction depth of 300 to 400 angstroms (Å). The task of producing a doped region having both a junction depth of less than 300 or 400 Å and a suitably low sheet resistance is more challenging. This task is rendered particularly difficult for p-type shallow doped regions by the implant and diffusion properties of boron, in particular. Significant issues in this regard include control of dopant channeling, reduction of thermal diffusion, and suppression of transient-enhanced diffusion, especially in the case of boron and phosphorus. Moreover, good device performance is only attained with a low sheet resistance of the shallow regions (i.e., with a high impurity concentration). The scaling tendency has been to reduce the ion implant energy while the total dopant level is kept more or less constant, and to reduce the thermal budget without significantly deteriorating the dopant activation level by introducing rapid thermal anneals and spike anneals.
This conventional scaling is expected to become difficult below the 300 to 400 Å junction depths, particularly for p+ junctions. The technical difficulty in making a high-current, low-energy ion implantation beam may be alleviated by the use of plasma doping (alternatively called plasma immersion ion implantation). Alternative processes that avoid implantation altogether have also been considered. Examples of such processes include rapid thermal vapor phase doping, gas immersion laser doping, and solid state hot diffusion such as from a BSG (borosilicate glass), PSG (phosphorus silicon glass), or ASG (arsenic silicon glass) film. All of these processes, however, face one or more problems with manufacturability.
In the fabrication of ultra-thin silicon-on-insulator (SOI) devices (e.g., SOI thicknesses<100 Å) or Fin Field Effect Transistors (FinFETs) (e.g., thickness<200 Å), care should also be taken so that the device silicon is not amorphized as a result of the extension and halo implant processes. If the silicon is amorphized down to the bottom of the buried oxide (BOX) region, it then may “regrow” (following anneal) in the form of polycrystalline silicon. In addition, such regrowth could also create stacking faults, thereby possibly shorting the devices.
In conventional thick silicon structures, a high dose implantation is used to produce low-resistance silicon source/drain (S/D) extensions, and the amorphized silicon regrows from the silicon lattice at the amorphization front. However, these same high dose implants directly in ultra-thin silicon structures fully amorphize the silicon layer, resulting in a poor solid-phase regrowth of the epitaxial silicon, as no remaining template exists. Generally, the silicon regrows as polysilicon, or multiple crystal grains rather than one continuous crystal. This polysilicon will have a higher sheet resistance than regrown single crystal silicon, and the device will suffer low Ion.
One possible approach to preventing complete amorphization involves depositing an undoped oxide on top of the thin SOI, and thereafter implant through the oxide and into the film. However, in eliminating the amorphization in silicon, most of the dopant will remain in the oxide after the implant step. Accordingly, it would be desirable to be able to introduce the desired concentration of dopant into the silicon for extension and halo formation, but without amorphizing the silicon in the process.
The foregoing discussed drawbacks and deficiencies of the prior art are overcome or alleviated by a method for forming a semiconductor device. In an exemplary embodiment, the method includes defining a sacrificial layer over a single crystalline substrate. The sacrificial layer is implanted with a dopant species in a manner that prevents the single crystalline substrate from becoming substantially amorphized. The sacrificial layer is annealed so as to drive said dopant species from said sacrificial layer into said single crystalline substrate.
The present invention has industrial applicability in the area of semiconductor device processing and, in particular, to the formation of ultra-thin semiconductor devices having silicon regions undamaged (non-amorphized) by dopant implant operations.
These and other aspects of the invention are described in further detail below.
Referring to the exemplary drawings wherein like elements are numbered alike in the several Figures:
It has recently been found that implanted arsenic (As) within an oxide layer completely diffuses out of the oxide layer with a small thermal anneal budget, regardless of whether the bulk of the dopant concentration is located within the oxide layer following the implant step. A similar phenomenon has also been observed with BF2 dopant as well. For example, if a 1 keV arsenic implant is applied to a 35 Å layer of oxide on single crystal silicon, there will be no substantial amorphization of the underlying silicon. Moreover, it has been found that nearly all of the arsenic dopant diffuses out of the oxide layer during a subsequent annealing step. Therefore, this technique may be used as the basis for creating low resistance source/drain (S/D) extension junctions without amorphizing silicon.
As is the case with S/D extension formation, a thin SOI device can also be completely amorphized during a halo implant step. This can happen especially during a PFET halo implant, which is usually an arsenic or antimony implant. Arsenic begins to amorphize silicon at a dose of about 1×1014 atoms/cm2, while antimony (Sb) begins to amorphize at about 5×1013 atoms/cm2. Furthermore, an arsenic halo implant is done at high energies, such as at 50 keV, for example. If the dose exceeds the amorphization threshold, then the depth of the resulting amorphous layer will be about 500 Å, which is unacceptable for thin SOI devices. As the devices are scaled down, the situation becomes worse, since the silicon thickness will be decreased and the halo dose will be increased for future generation technologies.
Thus, in order to prevent amorphization by a halo implant, the same principle of using a sacrificial dopant layer may be applied. That is, a halo implant may be implemented within a thin oxide layer and thereafter diffused out. With this type of implant, however, the degree of implant damage created in the oxide layer may not be sufficient enough to facilitate subsequent dopant diffusion out of the oxide into silicon. Accordingly, a neutral damage creating species (such as Si, Ge or even noble gases, for example) may also be implanted into the oxide to create more damage. Other species that could also be implanted to facilitate more diffusion out of the oxide layer include, but are not limited to, fluorine (F) and indium (In).
Another significant advantage that arises out of diffusing the halo/extension implant out of an oxide layer is that the halo/extension will be sharper. In particular, the halo profile obtained with this method will have a much lower standard deviation as compared to a high-energy implanted halo, since the spread from the implant will be eliminated. This in turn will reduce the short-channel effects and enable further scaling of the devices.
In fully depleted devices (which occur as silicon thickness is reduced below 200-300 Å), the halo profile is fully depleted at nominal channel lengths. Since the amount of depleted charge is dependent on the silicon thickness, the threshold voltage of thin Si devices is sensitive to silicon thickness. This happens because the halo implant places more dose in thicker silicon than in thinner silicon. Furthermore, the variation in silicon thickness across the wafer (especially for a 300 mm wafer) is expected to increase as silicon thins down. Doping from the implanted oxide reduces the threshold sensitivity to silicon thickness, so long as the diffusion distance is less than the minimum silicon thickness.
Therefore, in accordance with an embodiment of the invention, there is disclosed a method for forming non-amorphous, ultra-thin semiconductor devices using a sacrificial implantation layer. More specifically, the present method may be implemented for fabricating low resistance S/D extension regions for ultra-thin semiconductor (e.g., silicon, germanium, etc.) devices. The present method is further useful in provide doping uniformity control for a halo implant, thereby yielding improved voltage threshold (Vt) characteristics and short channel effect control.
Briefly stated, after standard gate electrode formation, spacer deposition and etching steps, halo and extension regions for each device is covered with a thin sacrificial material (such as silicon oxide formed by oxidation of the substrate, or other suitable deposited or grown materials). The appropriate regions for doping are then opened in a photoresist mask and a low-energy, shallow ion implantation introduces a controlled dose of dopant into the overlying sacrificial thin film. The photomask is removed and reapplied for the opposite type dopant (n or p). An anneal sequence is then employed to drive the dopant from the sacrificial layer (e.g., oxide) into the semiconductor material. If a halo implant process is desired, it should be done prior to the extension processing. This sequence could then be employed as many times as necessary for the device complexity.
Referring generally now to
If the substrate 106 is silicon, the sacrificial layer 108 may include a thin oxide layer grown (or deposited) to an exemplary thickness of about 15-100 Å. In addition to an oxide layer, the sacrificial layer 108 may also be a nitride film, oxynitride film or other dielectric film formed by available mechanisms in the art such as thermal oxidation, chemical vapor deposition (CVD), plasma enhanced CVD (PECVD), and high density plasma (HDP) CVD for example. Regardless of the type of material used, the sacrificial layer material will become a solid-source for diffusion once it is doped with a dopant species by implantation.
As explained previously, in certain situations the dopant implant dose for a halo implant may not provide sufficient damage to the sacrificial layer 108 (e.g., to an oxide layer). Accordingly,
Referring to
Once the halo and extension implants are completed in a non-amorphous manner, the device fabrication may continue in accordance with conventional processing techniques. In
As will be appreciated, the above described problems of conventional device fabrication in ultra-thin semiconductor architectures (i.e., direct ion implantation into the silicon crystal) have been overcome by the formation of highly doped, low resistance S/D extensions without the deleterious effects of amorphizing implants. When applied to device halo implants, the present method results in more abrupt doping profiles with better short channel effect (SCE) device characteristics than can be obtained with conventional implantation doping. The device operation will also be enhanced by the reduced Vt variation within the individual devices of the chip due to the more precise halo shape and resistance.
The use of a thin sacrificial layer (such as an oxide layer), in direct contact with a thin semiconductor layer, to diffuse implanted dopant therein to the semiconductor material below, while similar to diffusion from a solid source such as doped polysilicon or BSG, is much easier to integrate in an existing process. For example, the masking of the implant location is relatively easy for an implant, while relatively hard for a CVD film. Also, the amount of dopant and the depth of the diffusion can be better controlled with the implant dose and the annealing recipe. By removing the amorphous layer in the semiconductor, the material remains crystalline, and will have low resistance when heavily doped by the diffusing species. Without this method, an ultra-thin device material will fully amorphize and regrow as a high resistivity, multi-grained material yielding poor device characteristics (e.g., Ion/Ioff ratio).
The halo implant is used to control the device Vt and short channel effect. In ultra thin devices, this halo implant can also amorphize the material, resulting in poor resistance and leaky junctions. By using this method of diffusion from the implanted sacrificial layer for halo formation, the dopant profiles will be steeper than in the implanted case, and will have better uniformity, resulting in improved short channel effects. The thickness of the semiconductor layer can vary by large relative amounts due to fabrication difficulties (e.g., ±5 nm in a 20 nm film), which can affect the Vt control of the devices. The use of an oxide-diffused halo will provide a shallower halo distribution that is independent of the layer thickness, and thus improve device Vt uniformity from layer thickness.
While the invention has been described with reference to a preferred embodiment or embodiments, it will be understood by those skilled in the art that various changes may be made and equivalents may be substituted for elements thereof without departing from the scope of the invention. In addition, many modifications may be made to adapt a particular situation or material to the teachings of the invention without departing from the essential scope thereof. Therefore, it is intended that the invention not be limited to the particular embodiment disclosed as the best mode contemplated for carrying out this invention, but that the invention will include all embodiments falling within the scope of the appended claims.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US03/38559 | 12/4/2003 | WO | 00 | 6/2/2006 |